Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Dick

Showing results (121-130 of 245) with videos related to

Pageof 25
Sort By:
Photodiagnosis and Photodynamic Therapy|November 12, 2023
Quality assessment of anterior segment OCT images: Development and validation of quality criteriaRadhika Pooja Patel, Harry Petrushkin, Katie Etherton, et al.
Experimental Eye Research|April 18, 2006
Differences in leukocyte phenotype and interferon-gamma expression in stroma and endothelium during corneal graft rejectionSusan M Nicholls, Sanjiv Banerjee, Francisco C Figueiredo, et al.
JAMA Ophthalmology|April 21, 2017
Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 TrialsJohn Sheppard, Avani Joshi, Keith A Betts, et al.
International Ophthalmology|October 13, 2016
Alemtuzumab-induced remission of multiple sclerosis-associated uveitisMark D Willis, Trevor P Pickersgill, Neil P Robertson, et al.
Acta Ophthalmologica|August 17, 2018
Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutationEster Carreno, Tim Clench, Laura R Steeples, et al.
Ocular Immunology and Inflammation|January 5, 2024
Long-Term Visual Outcome of Patients with Blau SyndromeElke O Kreps, Dalila Al Julandani, Catherine M Guly, et al.
The American Journal of Pathology|March 16, 2015
TNFα Regulates SIRT1 Cleavage during Ocular Autoimmune DiseasePeter J Gardner, Samia Yazid, Colin J Chu, et al.
The American Journal of Pathology|November 29, 2011
Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrierDavid A Copland, Jian Liu, Lauren P Schewitz-Bowers, et al.
Progress in Retinal and Eye Research|November 29, 2011
Interplay between innate and adaptive immunity in the development of non-infectious uveitisFrançois Willermain, James T Rosenbaum, Bahram Bodaghi, et al.
Biomaterials|March 25, 2008
Patterned growth of neuronal cells on modified diamond-like carbon substratesStephen Kelly, Edward M Regan, James B Uney, et al.
Pageof 25

Showing results (121-130 of 245) with videos related to

Sort By:
Pageof 25
Photodiagnosis and Photodynamic Therapy|November 12, 2023
Quality assessment of anterior segment OCT images: Development and validation of quality criteriaRadhika Pooja Patel, Harry Petrushkin, Katie Etherton, et al.
Experimental Eye Research|April 18, 2006
Differences in leukocyte phenotype and interferon-gamma expression in stroma and endothelium during corneal graft rejectionSusan M Nicholls, Sanjiv Banerjee, Francisco C Figueiredo, et al.
JAMA Ophthalmology|April 21, 2017
Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 TrialsJohn Sheppard, Avani Joshi, Keith A Betts, et al.
International Ophthalmology|October 13, 2016
Alemtuzumab-induced remission of multiple sclerosis-associated uveitisMark D Willis, Trevor P Pickersgill, Neil P Robertson, et al.
Acta Ophthalmologica|August 17, 2018
Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutationEster Carreno, Tim Clench, Laura R Steeples, et al.
Ocular Immunology and Inflammation|January 5, 2024
Long-Term Visual Outcome of Patients with Blau SyndromeElke O Kreps, Dalila Al Julandani, Catherine M Guly, et al.
The American Journal of Pathology|March 16, 2015
TNFα Regulates SIRT1 Cleavage during Ocular Autoimmune DiseasePeter J Gardner, Samia Yazid, Colin J Chu, et al.
The American Journal of Pathology|November 29, 2011
Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrierDavid A Copland, Jian Liu, Lauren P Schewitz-Bowers, et al.
Progress in Retinal and Eye Research|November 29, 2011
Interplay between innate and adaptive immunity in the development of non-infectious uveitisFrançois Willermain, James T Rosenbaum, Bahram Bodaghi, et al.
Biomaterials|March 25, 2008
Patterned growth of neuronal cells on modified diamond-like carbon substratesStephen Kelly, Edward M Regan, James B Uney, et al.
Pageof 25